For research use only. Not for therapeutic Use.
TAK-441 is a small-molecule inhibitor of the Hedgehog (Hh) signaling pathway, specifically targeting Smoothened (SMO), a key protein involved in the pathway. The Hedgehog pathway is crucial for cell growth and differentiation, and its dysregulation is implicated in various cancers, including basal cell carcinoma and medulloblastoma. TAK-441 has shown potential in preclinical and early clinical studies for inhibiting tumor growth by blocking aberrant Hedgehog signaling. It is being investigated as a targeted therapy for cancers driven by this pathway.
| Catalog Number | I009687 |
| CAS Number | 1186231-83-3 |
| Synonyms | 6-ethyl-N-[1-(2-hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-phenacyl-3-(2,2,2-trifluoroethoxy)pyrrolo[3,2-c]pyridine-2-carboxamide |
| Molecular Formula | C28H31F3N4O6 |
| Purity | ≥95% |
| InChI | InChI=1S/C28H31F3N4O6/c1-3-19-13-20-23(27(40)35(19)14-21(37)17-7-5-4-6-8-17)25(41-16-28(29,30)31)24(33(20)2)26(39)32-18-9-11-34(12-10-18)22(38)15-36/h4-8,13,18,36H,3,9-12,14-16H2,1-2H3,(H,32,39) |
| InChIKey | ZADWXQMNNVICKB-UHFFFAOYSA-N |
| SMILES | CCC1=CC2=C(C(=C(N2C)C(=O)NC3CCN(CC3)C(=O)CO)OCC(F)(F)F)C(=O)N1CC(=O)C4=CC=CC=C4 |
